GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd.

Overview
Date Founded

1924

Headquarters

GSK House,Dr. Annie Besant Road,Mumbai, Maharashtra 400030

Type of Company

Public

Employees (Worldwide)

4,364

Industries

Pharmaceuticals

Company Description

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The vaccines products include prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. The company was founded in 1924 and is headquartered in Mumbai, India.

Contact Data
Trying to get in touch with decision makers at GlaxoSmithKline Pharmaceuticals Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Senior Executive Director, Technical

Executive Director, Technical

Executive Director & Chief Financial Officer

Executive Director

Executive Director

Executive Vice President & General Counsel

President, US Pharmaceuticals

Head-Specialty

Commercial Head-Established Pharma Business

Managing Director

Board of Directors

Managing Director at HDFC Bank Ltd.

President at International Wine & Food Society /India

Executive Director at GlaxoSmithKline Pharmaceuticals Ltd.

Vice Chairman at TVS Capital Funds

Executive Director at GlaxoSmithKline Pharmaceuticals Ltd.

Executive Director & Chief Financial Officer at GlaxoSmithKline Pharmaceuticals Ltd.

Managing Director & Director at Bilt Paper BV

Managing Director at GlaxoSmithKline Pharmaceuticals Ltd.

Non-Executive Director Vice President, Head of Manufacturing & Supply Chain for Primary & Established Products-GSK's Pharmaceutical Business at GlaxoSmithKline Pakistan Ltd.

Former Director at GlaxoSmithKline Pharmaceuticals Ltd.

Paths to GlaxoSmithKline Pharmaceuticals Ltd.
Potential Connections via
Relationship Science
You
GlaxoSmithKline Pharmaceuticals Ltd.
Owners & Shareholders
Details Hidden

ABSLAMC-IM is a long-term, fundamental research-based investor which manages portfolios invested in equity, fixed-income and money-market instruments across regions and sectors. These assets are available via a wide range of financial vehicles including diversified or sector specific equity funds, fund of funds, hybrid and monthly income funds, debt and treasury products and offshore funds. These funds can be actively or passively managed. The firm’s equity fund invests in stocks/equity shares of companies of different market capitalization. Their debt mutual fund invests in a mix of debt investments such as treasury bills, government securities (G-Secs), corporate bonds and other money market instruments of varying maturities that seek to provide investors capital preservation and regular income. ABSLAMC-IM’s hybrid fund invests in a mix of growth oriented equity, capital preserving debt and other assets related instruments, which can vary proportionally over time or remain fixed.

Details Hidden

GIC-IP is an active manager which constructs a portfolio comprised of investments in Central/State securities, government guaranteed bonds and housing and infrastructure.

Details Hidden

ABSLAMC-IM is a long-term, fundamental research-based investor which manages portfolios invested in equity, fixed-income and money-market instruments across regions and sectors. These assets are available via a wide range of financial vehicles including diversified or sector specific equity funds, fund of funds, hybrid and monthly income funds, debt and treasury products and offshore funds. These funds can be actively or passively managed. The firm’s equity fund invests in stocks/equity shares of companies of different market capitalization. Their debt mutual fund invests in a mix of debt investments such as treasury bills, government securities (G-Secs), corporate bonds and other money market instruments of varying maturities that seek to provide investors capital preservation and regular income. ABSLAMC-IM’s hybrid fund invests in a mix of growth oriented equity, capital preserving debt and other assets related instruments, which can vary proportionally over time or remain fixed.

Recent Transactions
Details Hidden

Hetero Drugs Ltd., Hetero Labs Ltd. purchase Glaxosmithkline Pharmaceuticals Ltd. /Vemgal Facility from GlaxoSmithKline Pharmaceuticals Ltd.

Details Hidden

FDC Ltd. purchases Glaxosmithkline Pharmaceuticals Ltd/ Enteroplus from GlaxoSmithKline Pharmaceuticals Ltd.

Details Hidden

GlaxoSmithKline Plc purchases GlaxoSmithKline Pharmaceuticals Ltd.

Transaction Advisors
Investment Advisor

Advised onGlaxoSmithKline Plc purchases GlaxoSmithKline Pharmaceuticals Ltd.

Advisors & Consultants
Consultant

President, Chief Executive Officer & Director at G1 Therapeutics, Inc.

Legal Advisor

Managing Partner at Dechert LLP

Legal Advisor

Partner at Dechert LLP

Clients

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Key Stats and Financials As of 2021
Market Capitalization
$3.72B
Total Enterprise Value
$3.18B
Earnings Per Share
$0.29
EBITDAMargin
21.96%
Enterprise Value / Sales
7.28x
Enterprise Value EBITDAOperating
33.14x
TEVNet Income
65x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
3.66%
Revenue
$438M
Total Equity
$205M
Total Debt
$4.74M
EBITDA
$96.1M
Net Profit
$49M
Political Donations
$500
2001
Suppliers
Hindusthan National Glass & Industries Ltd. Industrial Machinery & Manufacturing | Kolkata, Ind

Hindusthan National Glass & Industries Ltd. engages in the manufacture and sale of glass containers. Its products categories include food & beverages, pharmaceuticals & wellness, liquor & beer, and household & cosmetics. The company was founded by Chandra Kumar Somany on February 23, 1946 and is headquartered in Kolkata, India.

Empire Industries Ltd. (India) Other Business & Consulting Services | Mumbai, India

Empire Industries Ltd. operates as a diversified group of enterprises, whose manufacturing and marketing operations cover the areas of machine tools, industrial equipment, vending, foods, real estate and glass containers for pharmaceuticals. It also engages in manufacturing glass bottles, trading and indenting. It operates through the following segments: manufacturing; Trading, Business Support Service, Cosultancy, and Commission; Property Development and Others. The company was founded on October 17, 1900 and is headquartered in Mumbai, India.

GlaxoSmithKline Plc Medical Support Services | Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by GlaxoSmithKline Pharmaceuticals Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of GlaxoSmithKline Pharmaceuticals Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and GlaxoSmithKline Pharmaceuticals Ltd..